Rock Springs Capital Management LP Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$2.6B
Holdings
131
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $146.1M |
—GW PHARMACEUTICALS PLC | $118.0M |
AMRNAMARIN CORP PLC | $93.9M |
ISRGINTUITIVE SURGICAL INC | $87.0M |
WCGEURWELLCARE HEALTH PLANS INC | $86.3M |
NBIXNEUROCRINE BIOSCIENCES INC | $74.4M |
—SPARK THERAPEUTICS INC | $61.2M |
HCAHCA HEALTHCARE INC | $59.3M |
PCRXPACIRA PHARMACEUTICALS INC | $47.6M |
EHCENCOMPASS HEALTH CORP | $46.7M |
RAREULTRAGENYX PHARMACEUTICAL IN | $40.2M |
SRPTSAREPTA THERAPEUTICS INC | $39.9M |
TFXTELEFLEX INC | $39.3M |
IRTCIRHYTHM TECHNOLOGIES INC | $37.5M |
VRTXVERTEX PHARMACEUTICALS INC | $37.3M |
BSXBOSTON SCIENTIFIC CORP | $37.2M |
SYKSTRYKER CORP | $35.4M |
EWEDWARDS LIFESCIENCES CORP | $35.1M |
EXASEXACT SCIENCES CORP | $34.4M |
PENPENUMBRA INC | $33.1M |
ALXNALEXION PHARMACEUTICALS INC | $32.8M |
MDGLMADRIGAL PHARMACEUTICALS INC | $32.0M |
—PORTOLA PHARMACEUTICALS INC | $30.4M |
AFWALIGN TECHNOLOGY INC | $29.9M |
MOHMOLINA HEALTHCARE INC | $29.5M |
—WRIGHT MED GROUP N V | $29.0M |
ONCBEIGENE LTD | $28.4M |
ACHCACADIA HEALTHCARE COMPANY IN | $27.1M |
NVTA1EURINVITAE CORP | $26.9M |
IDXXIDEXX LABS INC | $26.9M |
INCYINCYTE CORP | $26.9M |
PRAHPRA HEALTH SCIENCES INC | $26.5M |
ASNDASCENDIS PHARMA A S | $25.1M |
IM8NINSMED INC | $24.7M |
BAXBAXTER INTL INC | $24.4M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $23.9M |
—RADIUS HEALTH INC | $23.4M |
BIIBBIOGEN INC | $23.0M |
ARGXARGENX SE | $22.7M |
TMOTHERMO FISHER SCIENTIFIC INC | $22.2M |
2L9BLUEPRINT MEDICINES CORP | $22.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $21.8M |
—EPIZYME INC | $21.7M |
—ALDER BIOPHARMACEUTICALS INC | $21.3M |
CVETUSDCOVETRUS INC | $20.7M |
—AUDENTES THERAPEUTICS INC | $20.4M |
—MEDICINES CO | $20.4M |
GLPGGALAPAGOS NV | $19.4M |
—RETROPHIN INC | $18.8M |
—RA PHARMACEUTICALS INC | $18.0M |
PBYIPUMA BIOTECHNOLOGY INC | $17.8M |
SGENEURSEATTLE GENETICS INC | $17.7M |
CELGCELGENE CORP | $17.5M |
FGENEURFIBROGEN INC | $16.6M |
ALLKGUSDALLAKOS INC | $16.4M |
—IMMUNOMEDICS INC | $15.4M |
—INTERSECT ENT INC | $14.9M |
SG7SAGE THERAPEUTICS INC | $14.7M |
AG8AGILENT TECHNOLOGIES INC | $14.7M |
CICIGNA CORP NEW | $14.5M |
—OBSEVA SA | $14.3M |
GHGUARDANT HEALTH INC | $13.8M |
WSTWEST PHARMACEUTICAL SVSC INC | $13.8M |
AM6AMICUS THERAPEUTICS INC | $13.6M |
—BIOHAVEN PHARMACTL HLDG CO L | $13.4M |
MRTXEURMIRATI THERAPEUTICS INC | $13.2M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $13.0M |
—ZOGENIX INC | $12.9M |
AXGNAXOGEN INC | $12.7M |
TBPHTHERAVANCE BIOPHARMA INC | $12.5M |
ANABANAPTYSBIO INC | $12.4M |
ZLABZAI LAB LTD | $12.2M |
BMRNBIOMARIN PHARMACEUTICAL INC | $12.0M |
—RTI SURGICAL HOLDINGS INC | $11.7M |
—PHASEBIO PHARMACEUTICALS INC | $10.8M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $10.8M |
—DERMIRA INC | $10.5M |
—TRANSLATE BIO INC | $10.3M |
FIXXEURHOMOLOGY MEDICINES INC | $10.3M |
ACRSACLARIS THERAPEUTICS INC | $10.2M |
FRPTFRESHPET INC | $9.9M |
—ODONATE THERAPEUTICS INC | $9.8M |
AXNX*AXONICS MODULATION TECH INC | $9.6M |
CBAYUSDCYMABAY THERAPEUTICS INC | $9.5M |
NVCRNOVOCURE LTD | $9.4M |
CHRSCOHERUS BIOSCIENCES INC | $9.1M |
ASMBASSEMBLY BIOSCIENCES INC | $8.9M |
HRTXHERON THERAPEUTICS INC | $8.6M |
IFRXINFLARX NV | $8.5M |
—MYOVANT SCIENCES LTD | $8.3M |
—ACHILLION PHARMACEUTICALS IN | $8.0M |
AGIOAGIOS PHARMACEUTICALS INC | $7.9M |
—MERSANA THERAPEUTICS INC | $7.4M |
—CLEMENTIA PHARMACEUTICALS IN | $7.2M |
—BLUEBIRD BIO INC | $7.1M |
—FIVE PRIME THERAPEUTICS INC | $6.8M |
SPROSPERO THERAPEUTICS INC | $6.7M |
—GLOBAL CORD BLOOD CORPORATIO | $6.5M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $6.4M |
CLVSEURCLOVIS ONCOLOGY INC | $6.4M |
Page 1 of 2Next